{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:10:05Z","timestamp":1773965405755,"version":"3.50.1"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>Despite lack of evidence for a safety threshold for oxytocin dose rate, many hospital protocols specify a maximum rate. We investigated whether exceeding 20 milliunits\/min of oxytocin was associated with adverse outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This is a secondary analysis of a double-blind, single-center, randomized controlled trial of nulliparous patients with singleton gestations at 36 weeks of gestation or later who presented in spontaneous labor randomized 1:1 to either a high-dose oxytocin titration regimen (initial-incremental rate of 6 milliunits\/min) or standard-dose titration regimen (initial-incremental rate of 2 milliunits\/min) for labor augmentation. A maximum oxytocin dose rate limit was not specified in the study protocol. For this secondary analysis, outcomes of participants who received oxytocin and exceeded a dose rate of 20 milliunits\/min at any point in labor were compared with those whose rate remained at 20 milliunits\/min or less. In addition, the cumulative proportions of labor and birth outcomes were calculated for each maximum dose rate of oxytocin reached among this study cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Of the 1,003 participants in the parent trial, 955 (95.2%) received oxytocin, as planned, and were included, with 190 (19.9%) exceeding a maximum dose rate of 20 milliunits\/min. Those who exceeded 20 milliunits\/min were older and were more likely to have rupture of membranes as their trial entry indication, have hypertensive disorders of pregnancy, receive intrapartum magnesium sulfate infusion, and receive oxytocin for longer. Those whose maximum rates exceeded 20 milliunits\/min underwent cesarean delivery more frequently, but the majority (74%) still delivered vaginally. In multivariable analyses, there were no significant associations between maximum oxytocin dose rates greater than 20 milliunits\/min and cesarean delivery (adjusted odds ratio [aOR] 1.57, 95% CI 1.00\u20132.46), peripartum infection (aOR 0.69, 95% CI 0.41\u20131.19), postpartum hemorrhage (aOR 1.37, 95% CI 0.70\u20132.71), or neonatal intensive care unit (NICU) admission (aOR 1.72, 95% CI 0.89\u20133.31). Although 85% of spontaneous vaginal deliveries occurred at maximum oxytocin dose rates of 20 milliunits\/min or less, vaginal deliveries continued to occur at higher maximum dose rates. The cumulative proportions of NICU admissions and composite severe neonatal morbidity and mortality cases increased with increasing oxytocin dose rates even with maximum oxytocin dose rates at 20 milliunits\/min or less.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>In multivariable analyses, there are no significant differences in maternal or perinatal adverse outcomes based on exceeding 20 milliunits\/min of oxytocin. These data suggest that oxytocin dosing should be individualized to each patient and not be based on arbitrary thresholds.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n                    <jats:p>ClinicalTrials.gov, NCT02487797.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000005058","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T17:30:10Z","timestamp":1673976610000},"page":"379-386","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Maximum Dose Rate of Intrapartum Oxytocin Infusion and Associated Obstetric and Perinatal Outcomes"],"prefix":"10.1097","volume":"141","author":[{"given":"Moeun","family":"Son","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Grobman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie","family":"Dude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan M.","family":"Peaceman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bethany","family":"Stetson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"R1-20260319","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ajog.2014.01.026","article-title":"Safe prevention of the primary cesarean delivery","volume":"210","author":"Caughey","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"R2-20260319","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/AOG.0b013e31821e5f65","article-title":"Indications contributing to the increasing cesarean delivery rate","volume":"118","author":"Barber","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R3-20260319","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/AOG.0b013e3181b48ef5","article-title":"Induction of labor. ACOG Practice Bulletin No. 107. American College of Obstetricians and Gynecologists","volume":"114","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R4-20260319","doi-asserted-by":"crossref","first-page":"622.e1","DOI":"10.1016\/j.ajog.2008.01.039","article-title":"Improving patient safety and uniformity of care by a standardized regimen for the use of oxytocin","volume":"198","author":"Hayes","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20260319","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/00003081-200609000-00019","article-title":"Oxytocin for induction of labor","volume":"49","author":"Smith","year":"2006","journal-title":"Clin Obstet Gynecol"},{"key":"R6-20260319","doi-asserted-by":"crossref","first-page":"34 e1","DOI":"10.1016\/j.ajog.2007.12.015","article-title":"Effects of oxytocin-induced uterine hyperstimulation during labor on fetal oxygen status and fetal heart rate patterns","volume":"199","author":"Simpson","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R7-20260319","doi-asserted-by":"crossref","first-page":"e0227941","DOI":"10.1371\/journal.pone.0227941","article-title":"How much synthetic oxytocin is infused during labour? A review and analysis of regimens used in 12 countries","volume":"15","author":"Daly","year":"2020","journal-title":"PLoS One"},{"key":"R8-20260319","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/AOG.0000000000004399","article-title":"High-dose compared with standard-dose oxytocin regimens to augment labor in nulliparous women: a randomized controlled trial","volume":"137","author":"Son","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R9-20260319","first-page":"455","article-title":"Randomized, double-masked comparison of oxytocin dosage in induction and augmentation of labor","volume":"94","author":"Merrill","year":"1999","journal-title":"Obstet Gynecol"},{"key":"R10-20260319","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.3109\/14767058.2014.963046","article-title":"Factors associated with higher oxytocin requirements in labor","volume":"28","author":"Frey","year":"2015","journal-title":"J Maternal-Fetal Neonatal Med"},{"key":"R11-20260319","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1006\/bbrc.1998.9680","article-title":"Cellular mechanisms underlying magnesium sulfate inhibition of phasic myometrial contractions","volume":"252","author":"Phillippe","year":"1998","journal-title":"Biochem Biophysical Res Commun"},{"key":"R12-20260319","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.ajog.2005.11.045","article-title":"Effect of magnesium sulfate on contractile force and intracellular calcium concentration in pregnant human myometrium","volume":"194","author":"Fomin","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R13-20260319","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1097\/AOG.0000000000001711","article-title":"Management of preterm labor. Practice Bulletin No. 171. American College of Obstetricians and Gynecologists","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R14-20260319","doi-asserted-by":"crossref","first-page":"367.e1","DOI":"10.1016\/j.ajog.2017.05.023","article-title":"The association of single-nucleotide polymorphisms in the oxytocin receptor and G protein-coupled receptor kinase 6 (GRK6) genes with oxytocin dosing requirements and labor outcomes","volume":"217","author":"Grotegut","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R15-20260319","doi-asserted-by":"crossref","first-page":"214.e1","DOI":"10.1016\/j.ajog.2017.04.036","article-title":"Novel oxytocin receptor variants in laboring women requiring high doses of oxytocin","volume":"217","author":"Reinl","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R16-20260319","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0039-1694982","article-title":"The effect of maternal obesity on oxytocin requirements to achieve vaginal delivery","volume":"37","author":"Adams","year":"2020","journal-title":"Am J Perinatol"},{"key":"R17-20260319","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0002-9378(11)90619-X","article-title":"Factors affecting the dose response to oxytocin for labor stimulation","volume":"166","author":"Satin","year":"1992","journal-title":"Am J Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:00:21Z","timestamp":1773957621000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005058","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"assertion":[{"value":"2022-09-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}